Drug recall
Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx…
FDA recall event 67393 · Class III · Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Key facts
| Event ID | 67393 |
|---|---|
| Recall numbers | D-1155-2014 |
| Recalling firm | Mylan Institutional, Inc. (d.b.a. UDL Laboratories) |
| Product type | Drugs |
| Products | Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20 |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Failed Impurity/degradation Specification |
| Initiation date | Jan 28, 2014 |
| Report date | Mar 19, 2014 |
| Termination date | Jun 19, 2015 |
| City | Rockford |
| State | IL |
| Country | United States |
| FEI number | 1419886 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: